PEAK6 Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-55,800
Closed -$5.34M 5538
2020
Q4
$5.34M Sell
55,800
-8,400
-13% -$866K 0.01% 1028
2020
Q3
$7.29M Sell
64,200
-45,800
-42% -$4.81M 0.02% 753
2020
Q2
$10.9M Buy
+110,000
New +$8.78M 0.04% 454
2019
Q2
Sell
-21,900
Closed -$1.39M 4309
2019
Q1
$1.39M Buy
+21,900
New +$1.15M 0.01% 1568

Other funds holding TNDM

PEAK6 Investments's TNDM Position: Q1 2023 in Review

PEAK6 Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 4,941 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in TNDM in Q4 2019 and held it in 6 quarters. The position peaked at $946K in Q3 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • PEAK6 Investments reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 4,941 Tandem Diabetes Care shares in Q1 2023, an estimated $222K.
  • PEAK6 Investments first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 6 quarters.
  • PEAK6 Investments's Tandem Diabetes Care position peaked at $946K in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.